Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19
P Zapolnik, W Kmiecik, A Mazur, H Czajka - International Journal of …, 2023 - mdpi.com
The Bacillus Calmette–Guérin (BCG) vaccine has been in use for over 100 years. It protects
against severe, blood-borne forms of tuberculosis. Observations indicate that it also …
against severe, blood-borne forms of tuberculosis. Observations indicate that it also …
Cyclic di-AMP as endogenous adjuvant enhanced BCG-induced trained immunity and protection against Mycobacterium tuberculosis in mice
H Ning, J Kang, Y Lu, X Liang, J Zhou, R Ren… - Frontiers in …, 2022 - frontiersin.org
Bacillus Calmette-Guérin (BCG) is a licensed prophylactic vaccine against tuberculosis (TB).
Current TB vaccine efforts focus on improving BCG effects through recombination or genetic …
Current TB vaccine efforts focus on improving BCG effects through recombination or genetic …
BCG and SARS-CoV-2—What Have We Learned?
J Kulesza, E Kulesza, P Koziński, W Karpik, M Broncel… - Vaccines, 2022 - mdpi.com
Despite controversy over the protective effect of the BCG (Bacille Calmette-Guérin) vaccine
in preventing pulmonary tuberculosis (TB) in adults, it has been used worldwide since 1921 …
in preventing pulmonary tuberculosis (TB) in adults, it has been used worldwide since 1921 …
Туберкулез и COVID-19: медицинские и социальные аспекты
ЕВ Савинцева, ПВ Исаева… - Туберкулез и болезни …, 2022 - tibl-journal.com
Аннотация В обзоре рассмотрены данные из 28 источников литературы о взаимном
влиянии COVID-19 и туберкулеза. Описываются диагностика, клинические проявления …
влиянии COVID-19 и туберкулеза. Описываются диагностика, клинические проявления …
Clinical and laboratory profile and outcomes of hospitalized COVID‐19 patients with type 2 diabetes mellitus in Ghana–A single‐center study
YO Hardy, E Libhaber, E Ofori… - Endocrinology …, 2023 - Wiley Online Library
Abstract Background In sub‐Saharan Africa and particularly in Ghana, there is scarcity of
published literature specifically on the impact of DM on outcomes in COVID‐19 patients …
published literature specifically on the impact of DM on outcomes in COVID‐19 patients …
The longevity-frailty hypothesis: evidence from COVID-19 death rates in Europe
S Zahran, L Altringer, A Prasad - International Journal of Environmental …, 2022 - mdpi.com
By the end of spring (31 May), the COVID-19 death rate was remarkably unevenly
distributed across the countries in Europe. While the risk of COVID-19 mortality is known to …
distributed across the countries in Europe. While the risk of COVID-19 mortality is known to …
The impact of Bacillus Calmette-Guérin (BCG) vaccination on the course of COVID-19: effectiveness and possible mechanism
JK Gałązka - Journal of Education, Health and Sport, 2022 - apcz.umk.pl
Abstract Nowadays, Bacillus Calmette-Guérin (BCG) is the most commonly used vaccine
worldwide, used typically for tuberculosis but also in non-muscle invasive bladder cancer …
worldwide, used typically for tuberculosis but also in non-muscle invasive bladder cancer …
Mw: A Potential Non-Specific Vaccine as First Response to Future Viral Pandemics before SpecificVaccines are Available-Some Lessons from COVID-19 Pandemic
OK Bharti, A Avhad, J Kishore - … (E-ISSN: 2581 …, 2022 - medical …
In absence of an effective drug or vaccine in the initial phase of COVID-19 pandemic,
authors started searching the literature to repurpose existing drugs/vaccines. Mw vaccine, a …
authors started searching the literature to repurpose existing drugs/vaccines. Mw vaccine, a …
[引用][C] Kozi nski, P
J Kulesza, E Kulesza - Karpik, W - europepmc.org
Despite controversy over the protective effect of the BCG (Bacille Calmette-Guérin) vaccine
in preventing pulmonary tuberculosis (TB) in adults, it has been used worldwide since 1921 …
in preventing pulmonary tuberculosis (TB) in adults, it has been used worldwide since 1921 …